Drug Topics April 19, 2024
Brian Nowosielski

Representatives from the US Government Accountability Office (GAO) interviewed regulators from 5 states on pharmacy benefit manager laws.

The US Government Accountability Office (GAO) addressed the measures that states have taken to regulate pharmacy benefit managers (PBMs). Focusing on 5 states—Arkansas, California, Louisiana, Maine, and New York—the GAO found rules requiring drug-pricing transparency, pharmacy access, and licensure, among other things.

What’s the Issue?

PBMs are the “middlemen” between insurance plans, drug manufacturers, and patients. It is their job to administer prescription drug benefits and help control costs.1 However, they’ve come under recent fire for their ability to maliciously operate in the shadows to the detriment of patients and community pharmacies, which prompted the GAO’s report.

  • All 5 states enacted...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: GAO, Govt Agencies, Pharma, Pharma / Biotech, States, Survey / Study, Trends
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025
DOJ Accuses Walgreens of Filling Millions of Illegitimate Prescriptions
DOJ sues Walgreens for allegedly filling millions of illegal prescriptions, including opioids
Q&A: NCPA Announces Independent Community Pharmacy Consortium for Government Engagement
Texas system looks to expand central pharmacy capacity: 4 notes

Share This Article